Old Drugs, New Indications (Review)
暂无分享,去创建一个
[1] P. Cyr,et al. Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements. , 2022, Journal of managed care & specialty pharmacy.
[2] S. Suslina,et al. Development of Celecoxib Granules for Manufacturing of Prolonged Release Celecoxib Capsules and Tablets , 2022, Drug development & registration.
[3] P. Cowen,et al. The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study , 2021, Journal of psychopharmacology.
[4] Vagan Y. Terziyan,et al. Neural Networks With Disabilities: An Introduction to Complementary Artificial Intelligence , 2021, Neural Computation.
[5] H. Hermjakob,et al. Path4Drug: Data Science Workflow for Identification of Tissue-Specific Biological Pathways Modulated by Toxic Drugs , 2021, Frontiers in Pharmacology.
[6] R. Mittal,et al. Repurposing old molecules for new indications: Defining pillars of success from lessons in the past. , 2021, European journal of pharmacology.
[7] N. Vargesson,et al. Thalidomide: history, withdrawal, renaissance, and safety concerns , 2021, Expert opinion on drug safety.
[8] R. Goldman,et al. Bupropion for smoking cessation in adolescents , 2021, Canadian Family Physician Médecin de famille canadien.
[9] H. Pérez‐Sánchez,et al. Ligand-based virtual screening, molecular docking, and molecular dynamics of eugenol analogs as potential acetylcholinesterase inhibitors with biological activity against Spodoptera frugiperda , 2021, Molecular Diversity.
[10] Vivek P. Chavda,et al. Advanced Computational Methodologies Used in the Discovery of New Natural Anticancer Compounds , 2021, Frontiers in Pharmacology.
[11] H. Sonaye,et al. Drug repurposing: Iron in the fire for older drugs. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] C. Arce,et al. The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer , 2021, Frontiers in Oncology.
[13] E. Jimenez‐Solem,et al. Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study , 2021, Drugs - Real World Outcomes.
[14] E. Carboni,et al. Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success? , 2021, Frontiers in Neuroscience.
[15] Pravir Kumar,et al. Artificial intelligence to deep learning: machine intelligence approach for drug discovery , 2021, Molecular Diversity.
[16] N. Knoers,et al. Drug Repurposing for Rare Diseases. , 2021, Trends in pharmacological sciences.
[17] Fang-Xiang Wu,et al. Drug-drug similarity measure and its applications. , 2020, Briefings in bioinformatics.
[18] M. Ayoub,et al. Sildenafil in combination therapy against cancer: A literature review. , 2020, Current medicinal chemistry.
[19] N. Kalin,et al. Hormonal Treatments for Major Depressive Disorder: State of the Art. , 2020, The American journal of psychiatry.
[20] F. Cheng,et al. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 , 2020, Cell Discovery.
[21] V V Poroikov,et al. Computer-Aided Drug Design: from Discovery of Novel Pharmaceutical Agents to Systems Pharmacology , 2020, Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry.
[22] C. Bailly. Irinotecan: 25 years of cancer treatment. , 2019, Pharmacological research.
[23] Sean Ekins,et al. Exploiting machine learning for end-to-end drug discovery and development , 2019, Nature Materials.
[24] J. Posner. The Role of Precision Medicine in Child Psychiatry: What Can We Expect and When? , 2018, Journal of the American Academy of Child and Adolescent Psychiatry.
[25] S. Karahuseyinoglu,et al. C-Abl is not actıvated in DNA damage-induced and Tap63-mediated oocyte apoptosıs in human ovary , 2018, Cell Death & Disease.
[26] Савинкова Алена Валерьевна,et al. ВАРИАНТЫ И ПЕРСПЕКТИВЫ ПЕРЕПРОФИЛИРОВАНИЯ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ ДЛЯ ИСПОЛЬЗОВАНИЯ В ТЕРАПИИ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ , 2018 .
[27] D. Herndon,et al. Does Acute Propranolol Treatment Prevent Posttraumatic Stress Disorder, Anxiety, and Depression in Children with Burns? , 2017, Journal of child and adolescent psychopharmacology.
[28] Jacob K. Asiedu,et al. The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.
[29] M. Toumi,et al. Filling the gap in CNS drug development: evaluation of the role of drug repurposing , 2017, Journal of market access & health policy.
[30] Nicola Nosengo. Can you teach old drugs new tricks? , 2016, Nature.
[31] Sergey Plis,et al. Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data. , 2016, Molecular pharmaceutics.
[32] Günter Klambauer,et al. DeepTox: Toxicity Prediction using Deep Learning , 2016, Front. Environ. Sci..
[33] R. M. Owen,et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies , 2015, Nature Reviews Drug Discovery.
[34] Geoffrey E. Hinton,et al. Deep Learning , 2015, Nature.
[35] F. Leweke,et al. Drug repurposing and emerging adjunctive treatments for schizophrenia , 2015, Expert opinion on pharmacotherapy.
[36] Yan Zhao,et al. Drug repositioning: a machine-learning approach through data integration , 2013, Journal of Cheminformatics.
[37] Francisco Azuaje,et al. Drug interaction networks: an introduction to translational and clinical applications. , 2013, Cardiovascular research.
[38] Weida Tong,et al. In silico drug repositioning: what we need to know. , 2013, Drug discovery today.
[39] Julio Saez-Rodriguez,et al. Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties , 2012, PloS one.
[40] R. Sharan,et al. PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.